Although its roles as an immune checkpoint in immune and tumor cells have gained much attention, the role of TIM-3 in metabolic reprogramming of immune and cancer cells in the context of HCC has not yet been thoroughly investigated. Here, HAVCR2 is linked to hepatocellular carcinoma.